1. Academic Validation
  2. The CD97-PPM1G axis dampens antiviral immunity by dephosphorylating IRF7 in type I interferon pathway

The CD97-PPM1G axis dampens antiviral immunity by dephosphorylating IRF7 in type I interferon pathway

  • PLoS Pathog. 2026 Mar 3;22(3):e1014032. doi: 10.1371/journal.ppat.1014032.
Huasong Chang 1 Wenjing Qi 1 Rukun Yang 1 Peili Hou 1 Ran Kang 1 Xiaoyu Liu 1 Yingying Li 1 Hongmei Wang 1 Hongbin He 1
Affiliations

Affiliation

  • 1 Ruminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, Shandong, China.
Abstract

The activation of type I interferon (IFN-I) signaling is crucial for defending host cells against viral infections. A comprehensive IFN-I response necessitates the activation of several cellular factors, among them Interferon Regulator Factor 7 (IRF7). Nonetheless, the mechanisms governing IRF7 inactivation in response to viral Infection remain largely unknown. Here, we illustrate that Cluster of differentiation 97 (CD97), a G protein-coupled receptor, interacts with PPM1G via intracellular Arg-819 and Arg-822 residues. PPM1G then recruits and dephosphorylates IRF7, leading to its inhibition. CD97-mediated inactivation of IRF7 impedes its translocation into the nucleus and subsequent activation of IFN-I, ultimately promoting the viral replication. Moreover, mice lacking CD97 display heightened resistance to viral Infection. The compound sanguinarine (SANG) hinders viral replication by dampening CD97 expression. This study provides a basis for CD97 as a potential Antiviral target and SANG as a candidate Antiviral small molecule drug.

Figures
Products